APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu Vaccine

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Selected research

Market Analysis & Forecast

Global Flu Vaccine Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchFlu Vaccine Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu Vaccine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

Read the full market overview

In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).

This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.

Flu Vaccine Segment by Company

Sanofi Pasteur

CSL

GSK

Mylan

Hulan Bio

AstraZeneca

CCBIO

Flu Vaccine Segment by Type

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Flu Vaccine Segment by Application

For Children (6 months to 3 years)

For Adults and Children over 3 years

Flu Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Flu Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Trivalent Influenza Vaccine Major Manufacturers Table 3. Quadrivalent Influenza Vaccine Major Manufacturers Table 4. Global Flu Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. For Children (6 months to 3 years) Major Manufacturers Table 6. For Adults and Children over 3 years Major Manufacturers Table 7. Flu Vaccine Industry Trends Table 8. Flu Vaccine Industry Drivers Table 9. Flu Vaccine Industry Opportunities and Challenges Table 10. Flu Vaccine Industry Restraints Table 11. Global Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Flu Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Flu Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Flu Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Flu Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Flu Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global Flu Vaccine Sales by Region (2021-2026) & (M Doses) Table 18. Global Flu Vaccine Sales by Region (2027-2032) & (M Doses) Table 19. Global Flu Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Flu Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Flu Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Flu Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Flu Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Flu Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Flu Vaccine Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 26. Global Flu Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Flu Vaccine Manufacturers, Product Type & Application Table 29. Global Flu Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Flu Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Flu Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Flu Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Flu Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Flu Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Flu Vaccine Sales by Type (2021-2026) & (M Doses) Table 39. Global Flu Vaccine Sales by Type (2027-2032) & (M Doses) Table 40. Global Flu Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Flu Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Flu Vaccine Price by Type (2021-2026) & (US$/Dose) Table 43. Global Flu Vaccine Price by Type (2027-2032) & (US$/Dose) Table 44. Global Flu Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Flu Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Flu Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Flu Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 50. Global Flu Vaccine Sales by Application (2021-2026) & (M Doses) Table 51. Global Flu Vaccine Sales by Application (2027-2032) & (M Doses) Table 52. Global Flu Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Flu Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Flu Vaccine Price by Application (2021-2026) & (US$/Dose) Table 55. Global Flu Vaccine Price by Application (2027-2032) & (US$/Dose) Table 56. Sanofi Pasteur Company Information Table 57. Sanofi Pasteur Business Overview Table 58. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 59. Sanofi Pasteur Flu Vaccine Product Portfolio Table 60. Sanofi Pasteur Recent Development Table 61. CSL Company Information Table 62. CSL Business Overview Table 63. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 64. CSL Flu Vaccine Product Portfolio Table 65. CSL Recent Development Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 69. GSK Flu Vaccine Product Portfolio Table 70. GSK Recent Development Table 71. Mylan Company Information Table 72. Mylan Business Overview Table 73. Mylan Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 74. Mylan Flu Vaccine Product Portfolio Table 75. Mylan Recent Development Table 76. Hulan Bio Company Information Table 77. Hulan Bio Business Overview Table 78. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 79. Hulan Bio Flu Vaccine Product Portfolio Table 80. Hulan Bio Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 84. AstraZeneca Flu Vaccine Product Portfolio Table 85. AstraZeneca Recent Development Table 86. CCBIO Company Information Table 87. CCBIO Business Overview Table 88. CCBIO Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 89. CCBIO Flu Vaccine Product Portfolio Table 90. CCBIO Recent Development Table 91. North America Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Flu Vaccine Sales by Type (2021-2026) & (M Doses) Table 94. North America Flu Vaccine Sales by Type (2027-2032) & (M Doses) Table 95. North America Flu Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 96. North America Flu Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 97. North America Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Flu Vaccine Sales by Application (2021-2026) & (M Doses) Table 100. North America Flu Vaccine Sales by Application (2027-2032) & (M Doses) Table 101. North America Flu Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 102. North America Flu Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 103. North America Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 107. North America Flu Vaccine Sales by Country (2021-2026) & (M Doses) Table 108. North America Flu Vaccine Sales by Country (2027-2032) & (M Doses) Table 109. North America Flu Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 110. North America Flu Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 111. United States Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 112. Canada Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 113. Mexico Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 114. Europe Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Flu Vaccine Sales by Type (2021-2026) & (M Doses) Table 117. Europe Flu Vaccine Sales by Type (2027-2032) & (M Doses) Table 118. Europe Flu Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 119. Europe Flu Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 120. Europe Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Flu Vaccine Sales by Application (2021-2026) & (M Doses) Table 123. Europe Flu Vaccine Sales by Application (2027-2032) & (M Doses) Table 124. Europe Flu Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 125. Europe Flu Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 126. Europe Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 130. Europe Flu Vaccine Sales by Country (2021-2026) & (M Doses) Table 131. Europe Flu Vaccine Sales by Country (2027-2032) & (M Doses) Table 132. Europe Flu Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 133. Europe Flu Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 134. Germany Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 135. France Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 136. U.K. Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 137. Italy Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 138. Russia Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 139. Spain Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Sweden Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Poland Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 144. China Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 145. China Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 146. China Flu Vaccine Sales by Type (2021-2026) & (M Doses) Table 147. China Flu Vaccine Sales by Type (2027-2032) & (M Doses) Table 148. China Flu Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 149. China Flu Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 150. China Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 151. China Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 152. China Flu Vaccine Sales by Application (2021-2026) & (M Doses) Table 153. China Flu Vaccine Sales by Application (2027-2032) & (M Doses) Table 154. China Flu Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 155. China Flu Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 156. Asia Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Flu Vaccine Sales by Type (2021-2026) & (M Doses) Table 159. Asia Flu Vaccine Sales by Type (2027-2032) & (M Doses) Table 160. Asia Flu Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 161. Asia Flu Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 162. Asia Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Flu Vaccine Sales by Application (2021-2026) & (M Doses) Table 165. Asia Flu Vaccine Sales by Application (2027-2032) & (M Doses) Table 166. Asia Flu Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 167. Asia Flu Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 168. Asia Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 172. Asia Flu Vaccine Sales by Country (2021-2026) & (M Doses) Table 173. Asia Flu Vaccine Sales by Country (2027-2032) & (M Doses) Table 174. Asia Flu Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 175. Asia Flu Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 176. Japan Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 177. South Korea Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 178. India Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Australia Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Flu Vaccine Sales by Type (2021-2026) & (M Doses) Table 185. SAMEA Flu Vaccine Sales by Type (2027-2032) & (M Doses) Table 186. SAMEA Flu Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 187. SAMEA Flu Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 188. SAMEA Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Flu Vaccine Sales by Application (2021-2026) & (M Doses) Table 191. SAMEA Flu Vaccine Sales by Application (2027-2032) & (M Doses) Table 192. SAMEA Flu Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 193. SAMEA Flu Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 194. SAMEA Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 198. SAMEA Flu Vaccine Sales by Country (2021-2026) & (M Doses) Table 199. SAMEA Flu Vaccine Sales by Country (2027-2032) & (M Doses) Table 200. SAMEA Flu Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 201. SAMEA Flu Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 202. Brazil Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Argentina Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 204. Chile Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Colombia Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Peru Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Israel Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 209. UAE Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Turkey Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Iran Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Egypt Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Flu Vaccine Distributors List Table 216. Flu Vaccine Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Flu Vaccine Image Figure 2. Global Flu Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Trivalent Influenza Vaccine Image Figure 5. Quadrivalent Influenza Vaccine Image Figure 6. Global Flu Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Flu Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. For Children (6 months to 3 years) Image Figure 9. For Adults and Children over 3 years Image Figure 10. Global Flu Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Flu Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Flu Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Flu Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Flu Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Flu Vaccine Sales (2021-2032) & (M Doses) Figure 16. Global Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global Flu Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Flu Vaccine Sales YoY (2021-2032) & (M Doses) Figure 19. Europe Flu Vaccine Sales YoY (2021-2032) & (M Doses) Figure 20. China Flu Vaccine Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) Flu Vaccine Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa Flu Vaccine Sales YoY (2021-2032) & (M Doses) Figure 23. Global Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Flu Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Flu Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Flu Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global Flu Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Flu Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Flu Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Flu Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Flu Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global Flu Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Flu Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Flu Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Flu Vaccine Sales Share by Type (2021-2032) Figure 40. North America Flu Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Flu Vaccine Sales Share by Application (2021-2032) Figure 42. North America Flu Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Flu Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Flu Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Flu Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Flu Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Flu Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Flu Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Flu Vaccine Sales Share by Country (2021-2032) Figure 50. China Flu Vaccine Revenue Share by Type (2021-2032) Figure 51. China Flu Vaccine Sales Share by Type (2021-2032) Figure 52. China Flu Vaccine Revenue Share by Application (2021-2032) Figure 53. China Flu Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Flu Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Flu Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Flu Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Flu Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Flu Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Flu Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Flu Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Flu Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Flu Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Flu Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Flu Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Flu Vaccine Sales Share by Country (2021-2032) Figure 66. Flu Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Flu Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Applications
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
Companies covered
  • Sanofi Pasteur
  • CSL
  • GSK
  • Mylan
  • Hulan Bio
  • AstraZeneca
  • CCBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Flu Vaccine Market by Type
  3. 1.2.1 Global Flu Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Trivalent Influenza Vaccine
  5. 1.2.3 Quadrivalent Influenza Vaccine
  6. 1.3 Flu Vaccine Market by Application
  7. 1.3.1 Global Flu Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 For Children (6 months to 3 years)
  9. 1.3.3 For Adults and Children over 3 years
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Flu Vaccine Market Dynamics
  1. 2.1 Flu Vaccine Industry Trends
  2. 2.2 Flu Vaccine Industry Drivers
  3. 2.3 Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Flu Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Flu Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Flu Vaccine Revenue by Region
  3. 3.2.1 Global Flu Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Flu Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Flu Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Flu Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Flu Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Flu Vaccine Sales by Region
  9. 3.4.1 Global Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Flu Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Flu Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Flu Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Flu Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Flu Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Flu Vaccine Sales by Manufacturers
  6. 4.2.1 Global Flu Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Flu Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Flu Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Flu Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Flu Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Flu Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Flu Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Flu Vaccine Tier 1, Tier 2, and Tier 3
5 Flu Vaccine Market by Type
  1. 5.1 Global Flu Vaccine Revenue by Type
  2. 5.1.1 Global Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Flu Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Flu Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Flu Vaccine Sales by Type
  6. 5.2.1 Global Flu Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flu Vaccine Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Flu Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Flu Vaccine Price by Type
6 Flu Vaccine Market by Application
  1. 6.1 Global Flu Vaccine Revenue by Application
  2. 6.1.1 Global Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Flu Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Flu Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Flu Vaccine Sales by Application
  6. 6.2.1 Global Flu Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Flu Vaccine Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Flu Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Flu Vaccine Price by Application
7 Company Profiles
  1. 7.1 Sanofi Pasteur
  2. 7.1.1 Sanofi Pasteur Company Information
  3. 7.1.2 Sanofi Pasteur Business Overview
  4. 7.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
  6. 7.1.5 Sanofi Pasteur Recent Developments
  7. 7.2 CSL
  8. 7.2.1 CSL Company Information
  9. 7.2.2 CSL Business Overview
  10. 7.2.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSL Flu Vaccine Product Portfolio
  12. 7.2.5 CSL Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Flu Vaccine Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Flu Vaccine Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Hulan Bio
  26. 7.5.1 Hulan Bio Company Information
  27. 7.5.2 Hulan Bio Business Overview
  28. 7.5.3 Hulan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hulan Bio Flu Vaccine Product Portfolio
  30. 7.5.5 Hulan Bio Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Flu Vaccine Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 CCBIO
  38. 7.7.1 CCBIO Company Information
  39. 7.7.2 CCBIO Business Overview
  40. 7.7.3 CCBIO Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CCBIO Flu Vaccine Product Portfolio
  42. 7.7.5 CCBIO Recent Developments
8 North America
  1. 8.1 North America Flu Vaccine Market Size by Type
  2. 8.1.1 North America Flu Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Flu Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Flu Vaccine Price by Type (2021-2032)
  5. 8.2 North America Flu Vaccine Market Size by Application
  6. 8.2.1 North America Flu Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Flu Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Flu Vaccine Price by Application (2021-2032)
  9. 8.3 North America Flu Vaccine Market Size by Country
  10. 8.3.1 North America Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Flu Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Flu Vaccine Market Size by Type
  2. 9.1.1 Europe Flu Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Flu Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Flu Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Flu Vaccine Market Size by Application
  6. 9.2.1 Europe Flu Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Flu Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Flu Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Flu Vaccine Market Size by Country
  10. 9.3.1 Europe Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Flu Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Flu Vaccine Market Size by Type
  2. 10.1.1 China Flu Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Flu Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Flu Vaccine Price by Type (2021-2032)
  5. 10.2 China Flu Vaccine Market Size by Application
  6. 10.2.1 China Flu Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Flu Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Flu Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Flu Vaccine Market Size by Type
  2. 11.1.1 Asia Flu Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Flu Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Flu Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Flu Vaccine Market Size by Application
  6. 11.2.1 Asia Flu Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Flu Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Flu Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Flu Vaccine Market Size by Country
  10. 11.3.1 Asia Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Flu Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Flu Vaccine Market Size by Type
  2. 12.1.1 SAMEA Flu Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Flu Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Flu Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Flu Vaccine Market Size by Application
  6. 12.2.1 SAMEA Flu Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Flu Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Flu Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Flu Vaccine Market Size by Country
  10. 12.3.1 SAMEA Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Flu Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Flu Vaccine Value Chain Analysis
  2. 13.1.1 Flu Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Flu Vaccine Production Mode & Process
  6. 13.2 Flu Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Flu Vaccine Distributors
  9. 13.2.3 Flu Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst